Background
Because of its viral nature and the increasingly metabolic chronic liver diseases, hepatic fibrosis (HF) has become a major challenge to global health. However, there are still no approved effective therapies for HF. Circular RNAs (circRNAs) have emerged as new potential targets of liver diseases. Thus, this research aims to clarify the role of circ_0008494 in liver fibrosis and reveal its mechanism.
Methods
circRNA profiles were screened by RNA sequencing and the location of circ_0008494 was confirmed by fluorescence in situ hybridization assay in human liver fibrosis tissues. Bioinformatics analysis was used for result prediction and dual luciferase reporter, together with AGO-RIP and biotin-coupled miRNA capture assays, were used to determine miR-185-3p/collagen type I alpha 1 chain (Col1a1) as the target of circ_0008494. A stable circ_0008494-interfering cell line of the hepatic stellate cells (HSCs) was constructed and used to determine the regulatory mechanism of circ_0008494/ miR-185-3p/ Col1a1 axis.
Results
Hsa_circ_0008494 was significantly over-expressed and uniquely located at the cytoplasm of HSCs in human HF tissues. Together, dual luciferase reporter, AGO-RIP and biotin-coupled miRNA capture assays validated that circ_0008494 acted as a sponge of miR-185-3p. Rescue assays demonstrated suppressing circ_0008494 could inhibit HSCs’ activation, proliferation, migration and promote their apoptosis through miR-185-3p. In particular, the fibrosis indicator, Col1a1, was predicted as the direct target of miR-185-3p and the suppression of circ_0008494 inhibited the expression of Col1a1 by releasing miR-185-3p.
Conclusions
Knocking down circ_0008494 ameliorated fibrosis through the miR-185-3p/Col1a1 axis. circ_0008494 could be a promising treatment target for hepatic fibrosis.